Authors: Sokolovskaya, AA Zabotina, TN Blokhin, DY Inshakov, AN Mikhailov, AD Kadagidze, ZG Baryshnikov, AY

Citation: Aa. Sokolovskaya et al., CD95-deficient cells of Jurkat/A4 subline are resistant to drug-induced apoptosis, EXP ONCOL, 23(3), 2001, pp. 175-180

Authors: Sokolovskaya, AA Zabotina, TN Blokhin, DY Kadagidze, ZG Baryshnikov, AY

Citation: Aa. Sokolovskaya et al., Comparative analysis of apoptosis induced by various anticancer drugs in Jurkat cells, EXP ONCOL, 23(1), 2001, pp. 46-50

Authors: Polosukhina, ER Baryshnikov, AY Shishkin, YV Zabotina, TN Logacheva, NP Tupitsyn, NN Volkova, MA Turkina, AG Tsvetaeva, NV Golenkov, AK Shirin, AD Kataeva, EV Trifonova, EV Mitina, TA Mikhailova, IN Lysyuk, EY Mayakova, SA Kadagidze, ZG

Citation: Er. Polosukhina et al., Expression of antigen CD95(Fas/APO-1) mediating apoptosis in hemoblastosesusing monoclonal antibodies ICO-160., GEMATOL TR, 45(4), 2000, pp. 3-6

Authors: Baryshnikov, AY Polosukhina, ER Shishkin, YV Tupitsyn, NN Syrkin, AB Gavrikova, NV Andreeva, LY Zabotina, TN Mayakova, SA Kurmashev, VI Kadagidze, ZG

Citation: Ay. Baryshnikov et al., A new prognostic marker of acute lymphoblastic leukemia - antigen CD95(Fas/APO-1)., GEMATOL TR, 43(2), 1998, pp. 8-11